Determination of Response to Vedolizumab in a Prospective Treatment of Ulcerative Colitis and Crohn's Disease With The Help of Cutting Edge Technologies Pims Molecular Fingerprint and Npot Molecular Network
Latest Information Update: 19 Feb 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacodynamics
Most Recent Events
- 19 Feb 2020 New trial record